RxDoctor Payments Data

Bill Majdalany, MD

Vascular & Interventional Radiology · Burlington, VTNPI 1083737563

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (38.1%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Balt USA, LLC at 57.1% of the total. Reporting peaked in 2023 at $8,903 and has fallen 96.2% since, to $339 in 2025.

$18,466in general payments, 2019–2025

Across 35 payments — averaging $527.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Balt USA, LLC$11K
  • Guerbet LLC$4K
  • Boston Scientific$2K
  • Inari Medical, Inc.$500
  • Sirtex Medical Inc$483
  • Teleflex LLC$96
  • plus $117 from 2 others
$86,970in research payments, 2019–2025

Across 7 payments — averaging $12,424 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bard Peripheral Vascular, Inc.$64K
  • Sirtex Medical Inc$23K

What the payments were for

  • Consulting fees$7,03138%
  • Speaking & faculty fees$3,24018%
  • Travel & lodging$6,86437%
  • Food & beverage$1,3307%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few vascular & interventional radiology providers in Vermontto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$67,519
Medicare patients
314
Services billed
723

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Burlington

Where these figures come from

Is this you, or does something look wrong? →